Aptose Biosciences Inc. (APTO) Retained Earnings (Accumulated Deficit) USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Aptose Biosciences Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2017 to 2024.
  • Aptose Biosciences Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$525 M, a 9.87% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$525 M -$47.2 M -9.87% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$516 M -$51.2 M -11% Dec 31, 2023 10-Q 2024-05-14
Q3 2023 -$504 M -$49.3 M -10.8% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$492 M -$47.6 M -10.7% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$478 M -$44 M -10.1% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 -$464 M -$41.8 M -9.9% Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$454 M -$56.1 M -14.1% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 -$445 M -$57.7 M -14.9% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 -$434 M -$60.6 M -16.2% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 -$423 M -$65.4 M -18.3% Dec 31, 2021 10-K 2023-03-24
Q3 2021 -$398 M -$55.7 M -16.3% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 -$387 M -$57.7 M -17.5% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 -$373 M -$59.9 M -19.1% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 -$357 M -$55.2 M -18.3% Dec 31, 2020 10-K 2022-03-22
Q3 2020 -$342 M -$48.2 M -16.4% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 -$329 M -$41.8 M -14.6% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 -$313 M -$32.3 M -11.5% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 -$302 M -$26.3 M -9.53% Dec 31, 2019 10-K 2021-03-23
Q3 2019 -$294 M -$24.8 M -9.22% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 -$287 M -$23.5 M -8.9% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 -$281 M -$27.6 M -10.9% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 -$276 M -$28.9 M -11.7% Dec 31, 2018 10-K 2020-03-10
Q3 2018 -$269 M Sep 30, 2018 8-K 2019-03-12
Q2 2018 -$264 M Jun 30, 2018 8-K 2019-03-12
Q1 2018 -$254 M Mar 31, 2018 8-K 2019-03-12
Q4 2017 -$247 M Dec 31, 2017 8-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.